Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab

Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab

<AIM:> To evaluate the relationship between intravitreal bevacizumab (IVB) treatment and the levels of vitreous vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and vitreous-retina surface fibrosis in patients with proliferative diabetic retinopathy (PDR). &l...

Full description

Bibliographic Details
Main Authors:	Jiu-Ke Li, Fang Wei, Xiao-Hong Jin, Yuan-Min Dai, Hu-Shan Cui, Yu-Min Li
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2015-12-01
Series:	International Journal of Ophthalmology
Subjects:	proliferative diabetic retinopathy vascular endothelial growth factor basic fibroblast growth factor fibrosis bevacizumab
Online Access:	http://www.ijo.cn/en_publish/2015/6/20150622.pdf

Similar Items

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

Vitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular statusVitreous VEGF levels among patients with proliferative diabetic retinopathy depending on the general clinical status and ocular status
by: Vira S. Ponomarchuk, et al.
Published: (2021-08-01)

Concentrations of serum VEGF and bFGF in Mongolia patients with diabetic retinopathy
by: Jun Zhang, et al.
Published: (2016-07-01)

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects
by: Cengiz Alagöz, et al.
Published: (2016-10-01)

Preoperative intravitreal bevacizumab for proliferative diabetic retinopathy patients undergoing vitrectomy - First update
by: Efraín Pérez-Argandoña, et al.
Published: (2019-02-01)

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
by: Shakarchi FI, et al.
Published: (2018-12-01)

Intravitreal injection of Conbercept combined with PPV in the treatment of proliferative diabetic retinopathy
by: Zhou Ou, et al.
Published: (2021-06-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy
by: Qiao-Yun Gong, et al.
Published: (2022-11-01)

WTH FACTORS IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: A. N. Trunov, et al.
Published: (2017-04-01)

Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01)

Recent progress in the investigation of VEGF and PEDF of proliferative diabetic retinopathy
by: Xiao-Hong Chen, et al.
Published: (2015-01-01)

Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
by: J. Fernando Arevalo, et al.
Published: (2023-04-01)

Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab
by: Xuting Hu, et al.
Published: (2019-09-01)

Angiogenesis: bFGF and VEGF in breast carcinoma
by: Vujasinović Tijana, et al.
Published: (2006-01-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
by: Tsuyoshi Minami, et al.
Published: (2014-10-01)

Bevacizumab-assisted surgery in the treatment of severe proliferative diabetic retinopathy
by: Yan Liu, et al.
Published: (2018-02-01)

Morphological and ophthalmoscopic features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy
by: Vira S Ponomarchuk, et al.
Published: (2021-10-01)

ANGIOGENESIS IN PROLIFERATIVE DIABETIC RETINOPATHY: RERSPECTIVES OF ANTI-VEGF THERAPY (REVIEW OF LITERATURE)
by: V. I. Konenkov, et al.
Published: (2015-12-01)

VIOLATIONS OF CYTOKINE REGULATION IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY
by: D. V. Chernykh, et al.
Published: (2015-10-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Revascularization of immature retinas with retinopathy of prematurity using combination therapy of deferred laser treatment after a single intravitreal bevacizumab injection
by: Ju Seouk Lee, et al.
Published: (2023-03-01)

Curative effect of 25G vitrectomy combined with different anti-VEGF drugs on proliferative diabetic retinopathy
by: Yan-Xia Shang, et al.
Published: (2022-11-01)

The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs
by: Berker Bakbak, et al.
Published: (2016-01-01)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
by: Majid Abrishami, et al.
Published: (2021-11-01)

SERUM CONCENTRATIONS OF SOME ANGIOGENEIC FACTORS IN MULTIPLE MYELOMA: VEGF, bFGF IN MMP-9
by: Mojca Modic, et al.
Published: (2004-12-01)

Postvitrectomy diabetic vitreous hemorrhage in proliferative diabetic retinopathy
by: Lei Shi, et al.
Published: (2012-01-01)

Macular Edema Formation and Deterioration of Retinal Function after Intravitreal Bevacizumab Injection for Proliferative Diabetic Retinopathy
by: Hisanori Imai, et al.
Published: (2011-09-01)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01)

Results of research of brain-derived neurotrophic factor level (BDNF) in the vitreous body of patients with proliferative diabetic retinopathy
by: A.A. Putienko, et al.
Published: (2016-02-01)

Clinical observation on preoperative application of Bevacizumab in proliferative diabetic retinopathy
by: Qian-Fang Qi, et al.
Published: (2014-09-01)

Effect of Decorin and Bevacizumab on oxygen-induced retinopathy in rat models: A comparative study
by: Seda Duran Güler, et al.
Published: (2021-01-01)

Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy
by: Zhikun Yang, et al.
Published: (2023-05-01)

Reduced Expression of Erythropoietin After Intravitreal Ranibizumab in Proliferative Diabetic Retinopathy Patients—Retrospective Interventional Study
by: Li Chen, et al.
Published: (2021-09-01)

Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
by: Hui Wang, et al.
Published: (2020-06-01)

The Regenerative Potential of bFGF in Dental Pulp Repair and Regeneration
by: Keyue Liu, et al.
Published: (2021-07-01)

Characteristics of Patient with Proliferative Diabetic Retinopathy Underwent Anti-Vascular Endothelial Growth Factors Injection in Cicendo Eye Hospital, Bandung in January–December 2013
by: Marsha Rayfa Pintary, et al.
Published: (2016-06-01)

Effect of ranibizumab combined with vitrectomy on the serum VEGF-A and SDF-1 expression in patients with proliferative diabetic retinopathy
by: Wen Luo, et al.
Published: (2019-03-01)